Archemix Signs Aptamer Therapeutics Agreement with Lilly
Archemix also strengthens IP portfolio through patent license
22-Oct-2008 -
Archemix Corp. announced that it has signed an agreement with Eli Lilly and Company (Lilly) regarding aptamer therapeutic R&D evaluation and access to intellectual property. The agreement enables Archemix to license certain intellectual property rights from Lilly and, in return, Lilly has an ...
aptamer therapeutics
aptamers
diseases
+2